Knowledge Of Biosimilars: Survey Of 100+ U.S. Rheumatologists Shows Familiarity But Need For Further Education

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Dec 20, 2017, 10:00 ET

RIDGEFIELD, Conn., Dec. 20, 2017 /PRNewswire/ -- A Boehringer Ingelheim survey of U.S. rheumatologists shows familiarity with biosimilars but a need for education.

Contact:
Boehringer Ingelheim Pharmaceuticals, Inc.
Name: Susan Holz
Phone: 203-798-4265
Email: [email protected]

A Boehringer Ingelheim survey of U.S. rheumatologists shows familiarity with biosimilars but a need for education
A Boehringer Ingelheim survey of U.S. rheumatologists shows familiarity with biosimilars but a need for education

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.

21%

more press release views with 
Request a Demo

Also from this source

Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint

Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint

Boehringer Ingelheim, a 140-year-old family-owned biopharmaceutical company committed to improving human and animal health and advancing innovation,...
More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics